Bausch + Lomb Names Thomas J. Appio Interim CEO
The appointment is effective immediately. Brent Saunders and the board mutually agreed that Saunders will depart the company.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bausch + Lomb Names Thomas J. Appio Interim CEO, Expects to Raise 2026 Guidance
Bausch + Lomb and Bausch Health announced Thomas J. Appio’s appointment as interim Bausch + Lomb CEO and said they expect to raise full-year 2026 guidance.